FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA and Duke MOU on Cardiac Safety

[ Price : $8.95]

Federal Register notice: FDA signs a memorandum of understanding (MOU) with Duke University to establish a framework for collabora...

FDA Drug Info on Twitter

[ Price : $8.95]

FDA says it is sending drug information tweets on Twitter.

Atrial Fibrillation Ablation Device Study Design

[ Price : $8.95]

FDA publishes a guidance on clinical study designs for surgical ablation devices used to treat atrial fibrillation.

FDA Clears Test for Ovarian Cancer

[ Price : $8.95]

FDA clears a Vermillion 510(k) for Ova1, a test that can help detect ovarian cancer in a pelvic mass that is already known to requ...

FDA Clears St. Judes Enhanced EnSite System

[ Price : $8.95]

FDA clears a St. Jude Medical 510(k) for the EnSite Velocity Cardiac Mapping System.

B&L Targets Seniors, Boomers with DTC Lens Ads

[ Price : $8.95]

Bausch & Lomb says it is resuming DTC ads to baby boomers and seniors for its Crystalens.

Draft Guide on Ablation Devices

[ Price : $8.95]

Federal Register notice: FDA posts a draft guidance entitled Clinical Study Designs for Surgical Ablation Devices for Treatment of...

Starlix ANDA Approvals Answer Exclusivity Questions

[ Price : $8.95]

Attorney Kurt Karst explains how FDAs Starlix ANDA decisions answers questions raised about marketing exclusivity eligibility.

Merck Plans Talks on Gene-related IND Migraine Drug

[ Price : $8.95]

Merck says it plans to meet with regulatory authorities on one investigational migraine drug and has stopped development of anothe...

CDRH to Review 18 Violative LASIK Ads

[ Price : $8.95]

FDA says it will give appropriate review to 18 allegedly violative LASIK surgery ads sent to it by an anti-LASIK activists from Fl...